Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Aug;38(8):1327-1334.
doi: 10.1007/s11095-021-03081-1. Epub 2021 Aug 16.

Strategies for Browning Agent Delivery

Affiliations
Review

Strategies for Browning Agent Delivery

Wentao Zhang et al. Pharm Res. 2021 Aug.

Abstract

Obesity expands as a global climbing epidemic that is often correlated to cardiovascular diseases and endocrine disorders. Converting white adipocytes to brown adipocytes for enhanced energy expenditure has recently emerged as a promising anti-obesity treatment. However, the conventional approaches to apply browning agents systematically suffer from off-target effects, multiple dosage requirements, and poor patient compliance. To date, various delivery strategies have been reported to deliver browning agents for obesity treatment in a safer and more controllable manner. This review will discuss the latest designs in browning agent delivery systems with a focus on nanomedicines and transdermal patches.

Keywords: adipocyte; browning agent; drug delivery; nanoparticle; transdermal patch.

PubMed Disclaimer

Similar articles

Cited by

References

    1. GBD 2015 Obesity Collaborators, Afshin A, Forouzanfar MH, Reitsma MB, Sur P, Estep K, et al. Health effects of overweight and obesity in 195 countries over 25 years. N Engl J Med. 2017;377(1):13–27. - DOI
    1. Kopelman PG. Obesity as a medical problem. Nature. 2000;404(6778):635–43. - PubMed - DOI - PMC
    1. Araújo J, Cai J, Stevens J. Prevalence of optimal metabolic health in American adults: National Health and nutrition examination survey 2009–2016. Metab Syndr Relat Disord. 2018;17(1):46–52. - PubMed - DOI - PMC
    1. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004;89(6):2583–9. - PubMed - DOI - PMC
    1. Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology. 2007;132(6):2087–102. - PubMed - DOI - PMC

Substances

LinkOut - more resources

-